Charles Blaha
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$7.5MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $7.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 25, 2026 | NIH | SBIR Phase I An intracorporeal hemodialysis system (iHemo) enabling home hemodialysis | $355K | Silicon Kidney |
| Jul 30, 2025 | NIH | SBIR Phase II An intravascular Bioartificial Pancreas (iBAP) | $1.0M | Silicon Kidney |
| Apr 26, 2024 | NIH | SBIR Phase I The intracorporeal hemodialysis system (iHemo) for eliminating the mortality health disparity of rural and remote End-stage Kidney Disease patients | $257K | Silicon Kidney |
| Feb 29, 2024 | NIH | SBIR Phase II A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | $1.0M | Silicon Kidney |
| Feb 13, 2023 | NIH | SBIR Phase II A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | $1.0M | Silicon Kidney |
| Sep 19, 2019 | NIH | SBIR Phase I A high oxygen capacity cell scaffold for the intravascular bioartifical pancreas (iBAP) | $298K | Silicon Kidney |
| Sep 19, 2019 | NIH | SBIR Phase I A high oxygen capacity cell scaffold for the intravascular bioartifical pancreas (iBAP) | $298K | Silicon Kidney |
| Sep 19, 2019 | NIH | SBIR Phase I A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | $224K | Silicon Kidney |
| Jul 25, 2019 | NIH | SBIR Phase II An implantable hemodialyzer for treatment of End-stage Renal Disease | $738K | Silicon Kidney |
| Jul 19, 2019 | NIH | SBIR Phase II An intravascular Bioartificial Pancreas (iBAP) | $746K | Silicon Kidney |
| Sep 15, 2018 | NIH | SBIR Phase II An implantable hemodialyzer for treatment of End-stage Renal Disease | $757K | Silicon Kidney |
| Jul 11, 2018 | NIH | SBIR Phase II An intravascular Bioartificial Pancreas (iBAP) | $746K | Silicon Kidney |
Peer ranks
Federal funding#133
Awards as PI#97
Patents#505
Companies
- Silicon KidneyLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.